U.S. and World Newswire
:
Business
:
Funding and Investment
News
Epeius Biotechnologies Corporation Receives $400,000 Grant to Support Gene Therapy Trials for Pancreatic Cancer
Published: Mon, 19 Jun 2006, 16:07:00 GMT
SAN MARINO, CA - June 19 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today that the Company has been awarded a $400,000 grant by the Lazarex Cancer Foundation to expand and support ongoing cancer gene therapy clinical trials for advanced and metastatic pancreatic cancer.
 Rexin-G(TM) is the world's first targeted injectable gene therapy vector to be approved for use in clinical trials in the USA and abroad. When injected intravenously, Rexin-G(TM) seeks out and destroys metastatic cancer, without the systemic toxicity generally associated with chemotherapy.
Rexin-G recently gained Orphan Drug status as an effective treatment for pancreatic cancer in the United States, and is currently available in clinical trials in Rochester MN.
In a statement to the press, Ms. Dana Dornsife, President of the Lazarex Cancer Foundation said: "We are pleased to provide Epeius Biotechnologies Corporation the funds needed to expedite the development of such promising genetic medicines, which - by improving both the survival and the quality of life - provide cancer patients with more quality time."
More information: http://www.epeiusbiotech.com
NEWS SOURCE: Epeius Biotechnologies Corporation
Send2Press® is the originating wire service for this story.
» Read More Funding and Investment News
» Other Send2Press Industry News by Category
More Information and Media Contact:
For questions about this story, contact the news source:
»
Click Here for Contact Information
THE CONTENT OF THE ABOVE NEWS STORY WAS PROVIDED BY THE NEWS SOURCE WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT SEND2PRESS (THIS WEBSITE).
O T H E R R E S O U R C E S
T E R M S O F U S E
This article is Copr. © 1983-2008 Neotrope / Send2Press. Reproduction of this news article version requires written authorization. You may freely link to this article. Journalists (see the section "Journalist Resources" above) may use orig. news release as the basis for an article.
News Websites may republish the "news release" text version linked to above under "Journalist Resources" except must retain "Send2Press Newswire" as the source of this news if used verbatim. Websites which offer/sell PR or newswire services, or web promotion services, or "splogs" may NOT reprint our content in ANY form. Send2Press Newswire is a service mark of, and "Send2Press" is a registered trademark of, Neotrope. Creative Commons - Some Rights Reserved (3.0) - Attribution Required.
DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the source (Epeius Biotechnologies Corporation). The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: Epeius Biotechnologies Corporation Receives $400,000 Grant to Support Gene Therapy Trials for Pancreatic Cancer, Rexin-G, Lazarex Cancer Foundation, clinical trials in the USA and abroad, destroys metastatic cancer, chemotherapy, Dana Dornsife, Dr. Erlinda M. Gordon, Dr. Frederick L. Hall, California, california news, Jun 19, 2006.
VIEWED BY MEDIA (and public): 2663 times (1 today, 4 this week,
43 this month, 389 this year)
| Lucy Hood to Deliver Keynote Presentation at Private Capital Network Breakfast Meeting |
| LBA Group Makes Premier List of the 5,000 Fastest-Growing U.S. Businesses |
| Investors Evaluate Early Stage Companies through Online Videos at PlanHeaven |
| Infrastruct Security, Inc. Exceeds $20 Million Annual Revenue with New Round of Financing |
| Social Network Technology and VoIP Provider YFonGlobal Raises Second Angel Round for a Total of $1.8 Million |
| Napatech Receives USD 7.5 Million Venture Capital Funding |
| CADFORCE, Inc. Announces $3.1 Million in Venture Capital Financing |
| Epeius Biotechnologies Corporation Receives $400,000 Grant to Support Gene Therapy Trials for Pancreatic Cancer |
| Crescent Diagnostics Secures Venture Capital Financing Investment to Advance the Development of its Novel Bone Quality Test |
| Authernative, Inc. Raises $2.5 Million in Series A Funding to Extend Its Position as Emerging Provider of User Authentication and Identity Management Solutions |
| LFR Communications, Inc. dba Graphcard.com to Raise $5,000,000 Via Private Placement |
| Napatech Receives $5 Million Venture Capital Funding |
| InSciTek Secures $2 Million in Additional Funding from Enhanced Capital Partners LLC |
| Point to Point, Inc. Announces Emergence from Bankruptcy; Components of Bankruptcy Financing |
| CADFORCE Secures $1.7 Million in Series A Funding Led By Santa Barbara-Based Venture Capital Firm, Rincon Venture Partners |
| Symphony Wealth Management Group's Ovation Fund Blazes New Trails on the Efficient Frontier and the Utilization of ETFs |
| American Finance Finalizes Agreement on Global Oil Tools' Liabilities |
| First American Makes Equity Investment in ComplianceEase - Industry-Leading Technology Providers Partner to Offer Essential Bundled Solutions |
| BRANDCONTROL.NET Receives Second Round of Venture Capital Funding |
| InSciTek Successfully Closes $4.0 Million for the Allworx Product Line |
| 25 Security Industry CEOs and Presidents Share Their Views on Growth Trends and the Business of Security |
| Young Investing Phenom Unlocks the Keys to the Stock Market |
| New Source of Financial Information has Words of Caution for Retirees |
| Lehman Brothers' Chief Investment Officer and Managing Director, Private Investment Management to Speak at New England-Canada Business Council's May Luncheon Meeting |
| The Lyamec Corporation Reaches Milestone Expansions in Great Britain, France, Canada, and Libya |
» View All News Channels
» Press Release Services
» Send2Press Home Page
|
|
|
|
|
Subscribe in a reader
PLAIN TEXT FORMAT (UTF-8)
PDF FORMAT
